Title : Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status.

Pub. Date : 2004

PMID : 15047921






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To investigate the feasibility of topotecan in the treatment of relapsed SCLC patients with PS 2 scores, we retrospectively analyzed data from five clinical trials that included 479 patients who were treated with single-agent topotecan at a dose of 1.5 mg/m2/day on days 1-5 of a 21-day course. Topotecan taste 2 receptor member 64 pseudogene Homo sapiens